Clinical Studies Resource Centre Member Ontario Cancer Institute (OCI)
Keywords: phase I clinical trials, head and neck malignancies, clinical trial design and methodology, molecular targeted agents
Research Interests
Developmental Therapeutics and Phase I Clinical Trials of Novel Agents
Specifically, my interests are in the design and methodology of clinical trials, as well as the development of relevant biological endpoints for the newer classes of anti-tumor compounds.
I am also interested in elucidating any barriers that might exist in the enrollment of patients into clinical trials. I anticipate that definition of such barriers will enable the application of interventions to improve trial participation by eligible and informed patients.
My subspecialized disease site of expertise include head and neck and gastrointestinal malignancies.
Additional Appointments
Site Leader, Health Informatics Priority Platform, (PMH)
